This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sientra Post-Approval Study

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Sientra, Inc. Identifier:
First received: July 10, 2012
Last updated: May 5, 2017
Last verified: May 2017
This is a ten-year postapproval study to evaluate the long-term clinical performance of Sientra Silicone Gel Breast Implants under general conditions of use in the postmarket environment.

Breast Augmentation Breast Reconstruction Breast Revision

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: U.S. Postapproval Study of Sientra Silicone Gel Breast Implants

Resource links provided by NLM:

Further study details as provided by Sientra, Inc.:

Primary Outcome Measures:
  • Long-term safety of Sientra Silicone Gel Breast Implants in women [ Time Frame: 10-years ]

Estimated Enrollment: 5000
Study Start Date: April 2012
Estimated Study Completion Date: March 2025
Estimated Primary Completion Date: March 2025 (Final data collection date for primary outcome measure)
Gel Participants
Control Participants


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Women who receive Sientra Silicone Gel Breast Implants for augmentation, revision augmentation, reconstruction, and revision reconstruction. Control participants are candidates for and undergo aesthetic surgery other than implantation with Silicone Gel Breast implants.

Inclusion Criteria:

  1. Genetic female with US residency
  2. Is at least 18 years old for primary or revision reconstruction or 22 years old for primary or revision augmentation
  3. Agrees to Sientra study requirements

Exclusion Criteria:

  1. Has an active infection anywhere in body
  2. Has active cancer without adequate treatment
  3. Currently pregnant or nursing
  4. Has any condition or diagnosis that, in the investigator's opinion, would negatively affect ability to complete study requirements
  5. If control participant, has undergone breast implant surgery with silicone gel-filled breast implants
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01639053

United States, California
Sientra, Inc.
Santa Barbara, California, United States, 93117
Sponsors and Collaborators
Sientra, Inc.
Study Director: Sientra, Inc. Sponsor GmbH
  More Information

Responsible Party: Sientra, Inc. Identifier: NCT01639053     History of Changes
Other Study ID Numbers: CP-1007
Study First Received: July 10, 2012
Last Updated: May 5, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Sientra, Inc.:
Breast Augmentation
Breast Reconstruction
Breast Revision
Silicone breast implants processed this record on September 21, 2017